Semaglutide, brand name Wegovy, is a weekly injectable drug treatment approved by the U.S
Other reported effects include: Headaches and dizziness Nausea and gastrointestinal discomfort Allergic reactions to B12 formulations (rare) If you experience symptoms suggesting a severe allergic reaction (difficulty breathing, severe rash, swelling of face/throat), seek emergency medical attention immediately by calling 999 or attending A&E
A compounded preparation has no indications at all in the regulatory sense, because it has no approved label
While it is available as a research chemical, it is not approved for injection in humans
For weight management, Wegovy is only available through specialist NHS weight management services for patients meeting strict BMI and comorbidity criteria, though current supply constraints may affect availability